CVS Health Enters Biosimilars Market with Launch of Cordavis Subsidiary

cafead

Administrator
Staff member
  • cafead   Aug 24, 2023 at 10:32: AM
via Consumer healthcare brand CVS Health on Wednesday launched Cordavis, a wholly owned subsidiary focused on the growing U.S. biosimilars market that will work directly with manufacturers.

article source